Revitalization of the AVRA project
AVRA has been around for a couple of years, trying to put a new robot on the market. Initially, they were focusing on vascular surgery, with a novel robot architecture span off from DLR.
Later they disappeared, due to financial difficulties, yet earlier this year, they have become a fully reporting public U.S. company. Now the company is back with a new robot and new focus: skin resurfacing procedures!
"AVRA believes that its comprehensive and diverse team brings the necessary resources to develop and commercialize intelligent medical robotic systems, as well as in marketing, chain management, and the implementation of all other aspects of business operations.
Three applications dominate this market:
- Laser Treatments
- Micro-Needling (dermabrasion)
The AVRA Medical Robotics Systems' lightweight portability will allow for easy use in physicians clinics, ambulatory settings, and outpatients facilities alike. AVRA is focusing on truly innovative technology that is in line with current applications but delivers an innovative approach. AVRA is integrating image-guidance with navigation and organ-targeting to bring a system that is truly diverse and multidimensional. Having identified limitations in the predominantly non-autonomous systems, AVRA proposes a disruptive model, which considers design and development through a seamless collaboration of the surgeon, the engineer, and the scientist.
For skin resurfacing, AVRA plans to take advantage of recent technological improvements in motors, materials, and in high-resolution imaging to use robotic devices to assist the surgeon to autonomously or semi-autonomously treat damaged skin. Presently, we are not aware of any commercially available robotic devices designed for this application.
Medical Equipment AVRA is currently developing an intelligent medical robotic system for facial corrections (i.e., skin resurfacing) in partnership with the University of Central Florida (UCF), pursuant to a research agreement entered into with UCF effective as of May 1, 2016. Research Lab and AVRA 3D Parts
UCF is recognized particularly for its work in the area of medical robotic research and design, focusing on the guidance systems. We anticipate that application of this expertise will allow the AVRA medical robotic system to handle a wide array of the currently available tools in the market. The Company plans to target a large market for its initial robotic system, which currently includes such solutions as Botox and CO2 lasers used for keratosis removal and treatment of scarring, discoloration, and other skin problems that are often difficult to treat."